Skip to main content

Advertisement

SpringerLink
Log in

Management of Primary Hyperparathyroidism

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Primary hyperparathyroidism (PHPT) is the unregulated overproduction of parathyroid hormone (PTH) resulting in abnormal calcium homeostasis. The disease profile has evolved over the last century from symptomatic hyperparathyroidism to asymptomatic hyperparathyroidism. Primary hyperparathyroidism is a biochemical diagnosis. Parathyroidectomy is the only established cure for this disease. Every effort is made to localize the offending gland preoperaively with various imaging modalities. These localization studies along with intraoperative parathormone monitoring will direct the surgeon to either a focused parathyroidectomy or a four gland exploration. All symptomatic patients and asymptomatic patients who meet the criteria for surgery should undergo parathyroidectomy if no medical contraindications exist. Pharmacologic approaches are reserved for those patients unfit or unwilling to undergo surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

Not applicable.

References

  1. Tezelman S, Shen W, Shaver JK et al (1993) Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 218(3):300–309. https://doi.org/10.1097/00000658-199309000-00009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bilezikian JP, Silverberg SJ, Clinical practice (2004) Asymptomatic primary hyperparathyroidism. N Engl J Med 350(17):1746–1751. https://doi.org/10.1056/NEJMcp032200

    Article  CAS  PubMed  Google Scholar 

  3. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA (2015) Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone 73:1–7. https://doi.org/10.1016/j.bone.2014.12.003

    Article  PubMed  Google Scholar 

  4. Yeh MW, Ituarte PH, Zhou HC et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98(3):1122–1129. https://doi.org/10.1210/jc.2012-4022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Raue F, Jacubeit T, Minne H, Herfarth C, Ziegler R (1989) Primärer Hyperparathyreoidismus--Anderung eines Krankheitsbildes [Primary hyperparathyroidism--changes in the disease picture]. Med Klin (Munich) 84(4):178–182

    CAS  Google Scholar 

  6. Yadav SK, Johri G, Bichoo RA, Jha CK, Kintu-Luwaga R, Mishra SK (2020) Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease. Arch Endocrinol Metab 64(2):105–110. https://doi.org/10.20945/2359-3997000000211

    Article  PubMed  Google Scholar 

  7. Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin J (1995) Dose-response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab 80(1):254–257. https://doi.org/10.1210/jcem.80.1.7829622

    Article  CAS  PubMed  Google Scholar 

  8. Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, Wm O'F, Bl R (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14(10):1700–1707. https://doi.org/10.1359/jbmr.1999.14.10.1700

    Article  CAS  PubMed  Google Scholar 

  9. Vignali E, Viccica G, Diacinti D et al (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94(7):2306–2312. https://doi.org/10.1210/jc.2008-2006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415–5422. https://doi.org/10.1210/jc.2004-0028

    Article  CAS  PubMed  Google Scholar 

  11. Ambrogini E, Cetani F, Cianferotti L et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121. https://doi.org/10.1210/jc.2007-0219

    Article  CAS  PubMed  Google Scholar 

  12. Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137(9):1022–1028. https://doi.org/10.1001/archsurg.137.9.1022

    Article  PubMed  Google Scholar 

  13. Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C (1998) Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg 68(2):117–119. https://doi.org/10.1111/j.1445-2197.1998.tb04719.x

    Article  CAS  PubMed  Google Scholar 

  14. Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G (2015) Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100(8):3069–3073. https://doi.org/10.1210/jc.2015-2132

    Article  CAS  PubMed  Google Scholar 

  15. Miller PD, Bilezikian JP (2002) Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N98–N102

    PubMed  Google Scholar 

  16. Syed Z, Khan A (2000) Skeletal effects of primary hyperparathyroidism. Endocr Pract 6(5):385–388. https://doi.org/10.4158/EP.6.5.385

    Article  CAS  PubMed  Google Scholar 

  17. Harari A, Waring A, Fernandez-Ranvier G et al (2011) Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab 96(12):3679–3686. https://doi.org/10.1210/jc.2011-1571

    Article  CAS  PubMed  Google Scholar 

  18. Tezelman S, Rodriguez JM, Shen W, Siperstein AE, Duh QY, Clark OH (1995) Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy. J Am Coll Surg 180(1):81–87

    CAS  PubMed  Google Scholar 

  19. Sharretts JM, Simonds WF (2010) Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab 24(3):491–502. https://doi.org/10.1016/j.beem.2010.01.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Castellano E, Attanasio R, Gianotti L, Cesario F, Tassone F, Borretta G (2016) Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria. J Clin Endocrinol Metab 101(7):2728–2732. https://doi.org/10.1210/jc.2016-1513

    Article  CAS  PubMed  Google Scholar 

  21. Stephen AE, Mannstadt M, Hodin RA (2017) Indications for surgical management of hyperparathyroidism: a review. JAMA Surg 152(9):878–882. https://doi.org/10.1001/jamasurg.2017.1721

    Article  PubMed  Google Scholar 

  22. Zanocco K, Angelos P, Sturgeon C (2006) Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 140(6):874–882. https://doi.org/10.1016/j.surg.2006.07.032

    Article  PubMed  Google Scholar 

  23. Zanocco KA, Wu JX, Yeh MW (2017) Parathyroidectomy for asymptomatic primary hyperparathyroidism: a revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery 161(1):16–24. https://doi.org/10.1016/j.surg.2016.06.062

    Article  PubMed  Google Scholar 

  24. Mannoh EA, Thomas G, Solórzano CC, Mahadevan-Jansen A (2017) Intraoperative assessment of parathyroid viability using laser speckle contrast imaging. Sci Rep 7(1):14798. https://doi.org/10.1038/s41598-017-14941-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70(2):114–120

    PubMed  Google Scholar 

  26. Ajmi S, Sfar R, Trimeche S, Ben Ali K, Nouira M (2010) Scintigraphic findings in hungry bone syndrome following parathyroidectomy. Rev Esp Med Nucl 29(2):81–83. https://doi.org/10.1016/j.remn.2009.10.003

    Article  CAS  PubMed  Google Scholar 

  27. Gough I (2006) Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg 76(12):1048–1050. https://doi.org/10.1111/j.1445-2197.2006.03931.x

    Article  PubMed  Google Scholar 

  28. Richards ML, Thompson GB, Farley DR, Grant CS (2008) Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 196(6):937–943. https://doi.org/10.1016/j.amjsurg.2008.07.022

    Article  PubMed  Google Scholar 

  29. Patow CA, Norton JA, Brennan MF (1986) Vocal cord paralysis and reoperative parathyroidectomy. A prospective study. Ann Surg 203(3):282–285. https://doi.org/10.1097/00000658-198603000-00011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mariette C, Pellissier L, Combemale F, Quievreux JL, Carnaille B, Proye C (1998) Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbeck's Arch Surg 383(2):174–179. https://doi.org/10.1007/s004230050113

    Article  CAS  Google Scholar 

  31. Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK (2013) Reoperations for primary hyperparathyroidism--improvement of outcome over two decades. Langenbeck's Arch Surg 398(1):99–106. https://doi.org/10.1007/s00423-012-1004-y

    Article  Google Scholar 

  32. Weber CJ, Sewell CW, McGarity WC (1994) Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation. Surgery 116(6):991–998

    CAS  PubMed  Google Scholar 

  33. Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 99(10):3607–3618. https://doi.org/10.1210/jc.2014-1417

    Article  CAS  Google Scholar 

  34. Wilkins BJ, Lewis JS Jr (2009) Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 3(2):140–149. https://doi.org/10.1007/s12105-009-0115-4

    Article  PubMed  PubMed Central  Google Scholar 

  35. Givi B, Shah JP (2010) Parathyroid carcinoma. Clin Oncol (R Coll Radiol) 22(6):498–507. https://doi.org/10.1016/j.clon.2010.04.007

    Article  CAS  Google Scholar 

  36. Wynne AG, van Heerden J, Carney JA et al (1992) Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 71(4):197–205

    Article  CAS  Google Scholar 

  37. Schantz A, Castleman B, Parathyroid carcinoma (1973) A study of 70 cases. Cancer 31(3):600–605. https://doi.org/10.1002/1097-0142(197303)31:3<600::aid-cncr2820310316>3.0.co;2-0

    Article  CAS  PubMed  Google Scholar 

  38. Silva-Figueroa AM, Hess KR, Williams MD et al (2017) Prognostic scoring system to risk stratify parathyroid carcinoma. J Am Coll Surg S1072-7515(17)30179. https://doi.org/10.1016/j.jamcollsurg.2017.01.060

  39. Montenegro FL, Chammas MC, Juliano AG, Cernea CR, Cordeiro AC (2008) Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma. Arq Bras Endocrinol Metabol 52(4):707–711. https://doi.org/10.1590/s0004-27302008000400019

    Article  PubMed  Google Scholar 

  40. Stratigis S, Stylianou K, Mamalaki E et al (2008) Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol 69(4):542–548. https://doi.org/10.1590/s0004-27302008000400019

    Article  CAS  Google Scholar 

Download references

Code Availability

Not applicable.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, PD Hinduja National Hospital and Research Centre, Mumbai, India

    Murad Lala

Authors
  1. Murad Lala
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murad Lala.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Agree.

Conflict of Interest

The author declares no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lala, M. Management of Primary Hyperparathyroidism. Indian J Surg Oncol 13, 143–151 (2022). https://doi.org/10.1007/s13193-021-01319-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-021-01319-3

Keywords

Search

Navigation